Synopsis
Objective: To
investigate the value of preoperative diffusion-weighted
magnetic resonance imaging for predicting aggressive histological
features in papillary thyroid cancer (PTC).
Methods: The
mean, minimum apparent diffusion coefficient (ADCmean and ADCmin) and ADC value
of the solid component (ADCsolid) were compared among different aggressive histological
groups. Analyses
of receiver-operating characteristic curve were also performed.
Results: The
ADC value in the low aggressive PTC were significantly higher than in high
aggressive PTC. ADCmin values had the best performance.
Conclusion:
ADCmin values derived from DWI could be used as quantitative predictors of
aggressive histological features in PTC.
Introduction
Papillary
thyroid carcinoma (PTC) has a favorable prognosis, with a mortality of 1~2% at
20 years (1). Patients with low
aggressive PTC have a disease-specific survival rate of more than 99% (2). Thyroidectomy without prophylactic central
neck dissection (PCND) may be appropriate for small (T1 or T2), noninvasive,
clinically node-negative (cN0) PTCs. Thyroid lobectomy alone may be enough for
the initial treatment of low aggressive PTC (3).
Therefore, accurate risk
stratification and predicting tumor aggressiveness is the cornerstone for
decision making in the management of thyroid cancer (3).
Fine-needle
aspiration (FNA) is one of the most accurate and cost-effective methods for
evaluating thyroid nodules, while can only provide few information with regards
to tumor aggressiveness (4). Ultrasound
(US) is used as a diagnostic tool of thyroid nodules (5, 6). However, US evaluation is an operator-dependent procedure
and cannot always be relied on.
Diffusion-weighted
imaging (DWI) is a functional magnetic resonance imaging (MRI) technique that
quantifies the diffusion of water molecules in tissues (7). Apparent diffusion coefficient (ADC) is a useful imaging
biomarker in diagnosis and predicting tumor grade (7, 8, 9). Based on a few reports, ADC values are associated
with papillary
thyroid carcinoma (PTC) aggressive phenotype
(10). However, studies performed to-date had
limited numbers of patients and only focused on the mean ADC value
(ADCmean) and did not include the minimum ADC (ADCmin) and ADC value of solid
component (ADCsolid) in PTC. Purpose
To investigate the value of
preoperative DWI for
predicting aggressive histological features in papillary thyroid cancer.Methods
In this prospective study, 88 patients with 88 PTCs were included. One-way ANOVA or Welch test were performed for multiple comparisons of the mean and minimum apparent diffusion coefficient (ADC) values (ADCmean and ADCmin) and ADC value of the solid component (ADCsolid) among the low aggressive PTC, high aggressive PTC without hobnail variants, and hobnail variants PTC groups. A nonparametric Kruskal-Wallis H test was used to analyze the difference of the lesion size among the three groups. Analyses of receiver-operating characteristic (ROC) curve were also performed.Results
The ADCmean, ADCmin and ADCsolid in the low aggressive PTC (1.35 ± 0.20 ×10-3mm2/s, 1.10 ± 0.17 ×10-3mm2/s, and 1.26 ± 0.23 ×10-3mm2/s, respectively) were significantly (P=0.003, P<0.001,and P<0.001, respectively) higher than in high aggressive PTC without hobnail variants (1.16 ± 0.17 ×10-3mm2/s, 0.88 ± 0.16 ×10-3mm2/s, 1.04 ± 0.17 ×10-3mm2/s, respectively). The size of the lesions in hobnail variants PTC (2.19 ± 1.21cm) was significantly larger (P<0.001) than that of low aggressive PTCs (0.93 ± 0.37cm). The area under the curve (AUC) for ADCmean, ADCmin and ADCsolid between the low aggressive PTCs and high aggressive PTCs without hobnail variants were 0.758, 0.851, 0.787, respectively.Discussion
To date, the quantitative study of thyroid nodules has concentrated around DWI. Many studies (11-12) have demonstrated that the ADCs of malignant thyroid nodules are significantly lower than those of benign nodules. Lu et al (10) evaluated whether, DWI before surgery could be used to stratify tumor aggressiveness in PTC. In their study the mean ADC values of PTCs with extrathyroidal extension (ETE) were significantly lower than that of PTCs without ETE. This is consistent with our study. However, our study had relatively large numbers of patients (88 vs 21) and additional parameters (ADCmean, ADCsolid and ADCmin vs ADCmean) were measured when compared with previous studies. We also used relatively high b value (800 s/mm2 vs 500 s/mm2), which was a very important factor that affects image quality and ADC measurements. In our study, high aggressive PTCs without hobnail variants showed significant lower ADCmean, ADCmin and ADCsolid values. ADCmin had the best performance for differentiating low aggressive PTCs from high aggressive PTCs without hobnail variants in this study. The mean AUC of ADCmin was 0.851, which demonstrated that ADCmin value might be a useful quantitative parameter in the preoperative prediction of PTC aggressiveness. Theoretically, the ADCmin value of a tumor corresponds with the highest tumor cellularity, which corresponds with the most active proliferative area. Studies have suggested that the ADCmin may be an effective parameter to differentiate between malignant and benign breast lesions and predictor of tumor grading (13-15). Our present study demonstrated that the optimal cut-off value for ADCmin was 0.982×10-3 mm2/s to differentiate low aggressive PTCs with high aggressive PTCs without hobnail variants. With ADCmin less than 0.982×10-3 mm2/s, the sensitivity and specificity for diagnosing high aggressive PTCs without hobnail variants were 79.66% and 90.48%, respectively.Conclusion
ADCmin values derived from DWI could be used as quantitative predictors of aggressive histological features during the preoperative evaluation of PTCs.Acknowledgements
We thank all members of
the Department of Radiology, Minhang Branch, Zhongshan Hospital, Fudan
University (Hao Wang, Ran Wei, Wenjuan Hu, Lanyun Wang, Yi Ding, Zedong Dai, Xilin Sun)and
all members of the Department of Pathology and General Surgery for helpful
discussions and invaluable help in manuscript preparation.References
(1) Brito JP, Hay ID, Morris JC. Low risk papillary thyroid cancer.
BMJ 2014;348: g3045
(2) Hay ID. Management of patients with low-risk papillary thyroid
carcinoma. Endocr Pract 2007;13: 521-533
(3) Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ,
Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines
for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The
American Thyroid Association Guidelines Task Force on Thyroid Nodules and
Differentiated Thyroid Cancer. Thyroid 2016; 26:1-133
(4) Baloch ZW, LiVolsi VA, Asa SL, Rosai J, Merino MJ, Randolph G,
et al. Diagnostic terminology and morphologic criteria for cytologic diagnosis
of thyroid lesions: a synopsis of the National Cancer Institute Thyroid
Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol 2008; 36:425-437
(5) Miyakoshi A, Dalley RW, Anzai Y. Magnetic resonance imaging of
thyroid cancer. Top Magn Reson Imaging 2007; 18:293-302
(6) Zhan J, Jin JM, Diao XH, Chen Y. Acoustic radiation force
impulse imaging (ARFI) for differentiation of benign and malignant thyroid
nodules--A meta-analysis. Eur J Radiol 2015; 84:2181-2186
(7) Waseda Y, Yoshida S, Takahara T, Kwee TC, Matsuoka Y, Saito K,
et al. Utility of computed diffusion-weighted MRI for predicting aggressiveness
of prostate cancer. J Magn Reson Imaging 2017; 46:490-496
(8) Nishie A, Tajima T, Asayama Y, Ishigami K, Kakihara D, Nakayama
T, et al. Diagnostic performance of apparent diffusion coefficient for
predicting histological grade of hepatocellular carcinoma. Eur J Radiol
2011;80: e29-33
(9) Lotfalizadeh E, Ronot M, Wagner M, Cros J, Couvelard A,
Vullierme MP, et al. Prediction of pancreatic neuroendocrine tumour grade with
MR imaging features: added value of diffusion-weighted imaging. Eur Radiol
(10) Lu Y, Moreira AL, Hatzoglou V, Stambuk HE, Gonen M, Mazaheri Y,
et al. Using diffusion-weighted MRI to predict aggressive histological features
in papillary thyroid carcinoma: a novel tool for pre-operative risk
stratification in thyroid cancer. Thyroid 2015
(11) Razek AA, Sadek AG, Kombar OR, Elmahdy TE, Nada N. Role of
apparent diffusion coefficient values in differentiation between malignant and
benign solitary thyroid nodules. AJNR Am J Neuroradiol 2008; 29:563-568
(12) Bozgeyik Z, Coskun S, Dagli AF, Ozkan Y, Sahpaz F, Ogur E.
Diffusion-weighted MR imaging of thyroid nodules. Neuroradiology 2009; 51:193-198
(13) Padhani AR, Koh DM. Diffusion MR imaging for monitoring of
treatment response. Magn Reson Imaging Clin N Am 2011; 19:181-209
(14) Hirano M, Satake H, Ishigaki S, Ikeda M, Kawai H, Naganawa S.
Diffusion-weighted imaging of breast masses: comparison of diagnostic
performance using various apparent diffusion coefficient parameters. AJR Am J
Roentgenol 2012; 198:717-722
(15) Kitis O, Altay H, Calli C, Yunten N, Akalin T, Yurtseven T.
Minimum apparent diffusion coefficients in the evaluation of brain tumors. Eur
J Radiol 2005; 55:393-400